• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

0.1701 -0.0038 (-2.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,445,041
Open 0.1761
Bid (Size) 0.1705 (15,000)
Ask (Size) 0.1737 (900)
Prev. Close 0.1739
Today's Range 0.1630 - 0.1779
52wk Range 0.1138 - 3.870
Shares Outstanding 75,993,532
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Friday's session: most active stocks ↗
August 21, 2026
Via Chartmill
Which stocks are moving before the opening bell on Friday? ↗
August 21, 2026
Via Chartmill

Performance

YTD
-94.1%
-94.1%
1 Month
-17.1%
-17.1%
3 Month
-19.4%
-19.4%
6 Month
-57.7%
-57.7%
1 Year
-93.1%
-93.1%

More News

Read More
News headline image
Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval
August 21, 2026
From Gossamer Bio, Inc.
Via Business Wire
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
August 14, 2026
Via Chartmill
News headline image
Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
From Gossamer Bio, Inc.
Via Business Wire
Check out the stocks that are attracting the most attention and driving market activity. ↗
July 28, 2026
Via Chartmill
News headline image
Undervalued Stocks in Focus: IGC, CISS, TOON, GOSS, KIDZ Enter Catalyst-Rich Growth Phase
July 28, 2026
Via AB Newswire
Topics Artificial Intelligence
Which stocks are moving before the opening bell on Tuesday? ↗
July 28, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
July 28, 2026
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
July 27, 2026
Via Benzinga
Top movers in Monday's after hours session ↗
July 27, 2026
Via Chartmill
Which stocks are moving on Monday? ↗
July 27, 2026
Via Chartmill
Curious about the most active stocks on Monday? ↗
July 27, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
July 27, 2026
Via Benzinga
Monday's session: top gainers and losers ↗
July 27, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Monday. ↗
July 27, 2026
Via Chartmill
News headline image
Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update
July 27, 2026
From Gossamer Bio, Inc.
Via Business Wire
Top movers in Monday's after hours session ↗
July 20, 2026
Via Chartmill
News headline image
Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes due 2030 and Exercise Price for Purchase Warrants
July 01, 2026
From Gossamer Bio, Inc.
Via Business Wire
Wondering what's happening in today's after-hours session? ↗
June 29, 2026
Via Chartmill
News headline image
Gossamer Bio, Inc. Announces Final Tender Results for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
June 17, 2026
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio, Inc. Announces Early Tender Results and Early Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
June 03, 2026
From Gossamer Bio, Inc.
Via Business Wire
News headline image
CLASS ACTION DEADLINE TONIGHT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline
June 01, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
June 01, 2026
From The Schall Law Firm
Via Business Wire
News headline image
Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
June 02, 2026
From Gossamer Bio, Inc.
Via Business Wire

Frequently Asked Questions

Is Gossamer Bio, Inc. - Common Stock publicly traded?
Yes, Gossamer Bio, Inc. - Common Stock is publicly traded.
What exchange does Gossamer Bio, Inc. - Common Stock trade on?
Gossamer Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Gossamer Bio, Inc. - Common Stock?
The ticker symbol for Gossamer Bio, Inc. - Common Stock is GOSS on the Nasdaq Stock Market
What is the current price of Gossamer Bio, Inc. - Common Stock?
The current price of Gossamer Bio, Inc. - Common Stock is 0.1701
When was Gossamer Bio, Inc. - Common Stock last traded?
The last trade of Gossamer Bio, Inc. - Common Stock was at 08/27/26 04:00 PM ET
What is the market capitalization of Gossamer Bio, Inc. - Common Stock?
The market capitalization of Gossamer Bio, Inc. - Common Stock is 12.93M
How many shares of Gossamer Bio, Inc. - Common Stock are outstanding?
Gossamer Bio, Inc. - Common Stock has 13M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap